Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for Treatment of gBRCA-mutated HER2-Negative Breast Cancer

U.S. Fast Track designation of ART6043 underpinned by promising clinical data to date and high unmet need in gBRCA-mutated HER2-negative breast ...
Business Wire

Promega Engineers New Enzyme to Significantly Reduce Stutter in Forensic DNA Analysis

Promega files patent for first-of-its-kind enzyme that minimizes stutter artifacts in STR analysis Reduced stutter polymerase enhances accuracy, efficiency and reliability of DNA profiling in forensic ...
The Scientist

Optimizing PCR: Proven Tips and Troubleshooting Tricks

Polymerase chain reaction (PCR) is a fundamental molecular biology tool that scientists use to amplify and analyze genetic material, such as DNA and RNA. PCR involves the enzymatic amplification of ...
CURE

FDA Grants Fast Track to ART6043 for BRCA-Mutated Advanced Breast Cancer

FDA fast track covers ART6043 plus olaparib in PARP inhibitor–naïve gBRCAm, HER2-negative locally advanced/metastatic breast ...